The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q)

The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q)The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q), Published online: 21 September 2018; doi:10.1038/s41408-018-0126-zThe impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q)

Source: Blood Cancer Journal - September 21, 2018 Category: Hematology Authors: Mikkael A. Sekeres Arlene S. Swern Aristoteles Giagounidis Alan F. List Dominik Selleslag Moshe Mittelman Brigitte Schlegelberger Gudrun G öhring Jack Shiansong Li Mary M. Sugrue Pierre Fenaux Source Type: research